Martínez-Montoya M, Hernández-Farías MÁ, Jaspersen-Gastelum J, Virgen-Gutiérrez F, Rosas-Ramírez A, Jaspersen-Álvarez J, Carillo-Córdova LD

Language: English
References: 16
Page: 414-418
PDF size: 235.38 Kb.

ABSTRACT

Background: Urolithiasis and metabolic syndrome are considered a worldwide pandemic, with important health system repercussions. Mexico has a high incidence of both pathologies. Identifying the predisposing factors of urolithiasis will prevent recurrence, complications, and surgical treatments.
Objective: To establish the prevalence of metabolic syndrome and evaluate the modifications in urolithiasis pathophysiology.
Materials and Methods: A non-randomized cross-sectional study was conducted on patients seen at the Hospital General de México Dr. Eduardo Liceaga, diagnosed with urolithiasis within the time frame of March to December 2016. Study variables: anthropometric measurements, blood pressure readings, and fasting glucose levels and lipid profiles.
Results: Eighty-four patients, 32 men and 52 women, were enrolled in the study. Their mean age was 47.3 ± 14.1 years. A total of 52% of the cases of urolithiasis corresponded to women. Metabolic syndrome was diagnosed in 58 of the study patients, 29% of whom were men and 71% women, representing a woman:man prevalence ratio of 3:1.
Conclusions: Urolithiasis should not be considered an isolated entity, but rather understood in a multifactorial context and as a systemic disease.

REFERENCES

1. Saenz-Medina J, et al. Review of the pathophysiological aspects involved in urological disease associated with metabolic syndrome. Actas Urol Esp 2016;40(5):279-87. DOI: 10.1016/j.acuro.2015.10.001

2. Domingos F, Serra A. Metabolic syndrome: a multifaceted risk factor for kidney stones. Scand J Urol. 2014;48(5):414-9. DOI: 10.3109/21681805.2014.903513

3. Barrera M, Pinilla A, Cortes E, et al. Síndrome metabólico: una mirada interdisciplinaria. Rev Colomb Cardiol 2008;15: 111-126.

4. Wong YV, et al. The association of metabolic syndrome and urolithiasis. Int J Endocrinol. 2015;2015:570674. DOI: 10.1155/2015/570674

5. Haymann JP. Metabolic disorders: stones as first clinical manifestation of significant diseases. World J Urol. 2015;33(2):187-92. DOI: 10.1007/s00345-014-1391-5

6. Aragón A, Hernández M. Análisis cristalográfico de 475 cálculos de vías urinarias en el hospital San José, Tec Salud en Monterrey, N.L. Rev Mex Urol 2013;73:130-5.

7. Cho ST, et al. Correlation of metabolic syndrome with urinary stone composition. Int J Urol. 2013;20(2):208-13. DOI: 10.1111/j.1442-2042.2012.03131.x

8. Shadman A, Bastani B. Kidney Calculi: Pathophysiology and as a Systemic Disorder. Iran J Kidney Dis 2017;11(3):180-91.

9. Broadus AE, Thier SO. Metabolic basis of renal-stone disease. N Engl J Med. 1979;300(15):839-45. DOI: 10.1056/ NEJM197904123001507

10. Zerifi R, et al. [Metabolic syndrome: pathophysiology and impact on lithogenesis]. Ann Biol Clin (Paris). 2008;66(1):9- 17. DOI: 10.1684/abc.2008.0187

11. Lizarzaburu, J. Síndrome metabólico: concepto y aplicación práctica. An Fac med. 2013;74(4):315-20.

12. Wong Y, et al. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature. J Endourol. 2016;30(3):246-53. DOI: 10.1089/end.2015.0567

13. Rendina D, et al. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014;27(4):371-6. DOI: 10.1007/ s40620-014-0085-9

14. Lee YC, et al. Impact of metabolic syndrome and its components on kidney stone in aging Taiwanese males. Aging Male 2016;19(3):197-201. DOI: 10.1080/13685538.2016.1174987

15. Rosas J, et al. Epidemiologia, diagnostico, control, prevención y tratamiento del síndrome metabólico en Adultos. ALAD 2010;18(1):25-44.

16. Sasaki Y, et al. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome. Int J Urol. 2015;22(4):404-9. DOI: 10.1111/iju.12691